Qiang Liu

20PUBLICATIONS

63CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cultural theoryPredictive and prognostic markersInnate immunity

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (20)

Sort by Publication Date:

|May 13, 2026

NFYA-Mediated TTK Up-Regulation Drives Fast Cell Cycle Progression and Its Inhibition Leads to Mitotic Catastrophe in Triple Negative Breast Cancer.

|Apr 04, 2026

Everolimus destabilizes thymidylate synthase via suppressing its O-GlcNAcylation and sensitizes HER2-negative breast cancer to fluorouracil.

Xiao-Ting Jiang, Huipei Gan, Shaoyi Wang

|Jan 12, 2026

De-escalation of axillary surgery after neoadjuvant therapy in breast cancer: long-term outcomes of sentinel lymph node biopsy alone versus complete axillary lymph node dissection.

Haizhu Chen, Xiaoyan Qian, Luhui Mao

|Dec 19, 2025

Introduction and impact of the young breast cancer in China consensus.

Xin Yang, Chao Dong, Qiang Liu

|Sep 30, 2025

Chemotherapy-induced CA-repeat DNA fragments in breast cancer trigger antitumor immune responses.

Xiaoqian Zhang, Penghan Huang, Huiping Chen

|Mar 22, 2025

Dynamic ctDNA tracking stratifies relapse risk for triple negative breast cancer patients receiving neoadjuvant chemotherapy.

Shunying Li, Yudong Li, Wei Wei

Pageof 4

Frequent Collaborators

Erwei Song

Shicheng Su

Xiaoqian Zhang

Jinna Lin

Yujie Liu

Xiaoting Jiang

Liang Jin

Lok Lam Wong

Qi Wang

Herui Yao

Frequent Collaborators

Erwei Song

Shicheng Su

Xiaoqian Zhang

Jinna Lin